HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Diagnosis, Management & Treatment

Advancements in diagnosis, management & treatment have significantly improved diabetes care, offering more precise and individualized approaches. Early diagnosis relies on fasting glucose, HbA1c levels, and continuous glucose monitoring, enabling timely intervention. Management strategies incorporate a combination of pharmacological treatments, lifestyle modifications, and emerging digital health technologies. While metformin remains a first-line therapy, newer agents such as GLP-1 receptor agonists and SGLT2 inhibitors provide cardiovascular and renal benefits beyond glycemic control. Insulin therapy continues to evolve, with ultra-long-acting formulations improving adherence. Personalized treatment plans integrating dietary counseling, physical activity, and behavioral support ensure optimal outcomes, while telemedicine and wearable devices enhance patient monitoring and engagement in diabetes self-care.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp